Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucocorticoid-induced HPA axis suppression in children with ALL or lymphoma
NL-OMON38085Active, not recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Dec 2010
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of prednisolone, dexamethasone and hydrocortisone in acute lymphoblastic leukemia (ALL), Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL) (4 arms), sponsored by Vrije University Medical Center. Primary endpoints: HPA axis suppression after glucocorticoid therapy, Recovery time of HPA axis function and 2 more. Started Dec 2010; status: active, not recruiting.
02
Drugs
prednisolonedexamethasonehydrocortisone
03
Conditions
acute lymphoblastic leukemia (ALL)Hodgkin lymphoma (HL)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NL-OMON38085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38085.